Correction to: Gene Therapy advance online publication, 19 May 2016; doi: 10.1038/gt.2016.41
The following statement should be noted under Conflict of Interest:
'KK, WH, and RK are named inventors on patents that cover the viral gene editing technology that is the subject of this published journal article. In addition to the foregoing interests, KK is a co-founder, board member, scientific advisor and holds equity in Excision Biotherapeutics, a biotech start-up which has licensed the viral gene editing technology from Temple University for commercial development and clinical trials. JG serves as an unpaid scientific advisor to Excision Biotherapeutics. The option to license the viral gene editing technology was signed before the acceptance of this manuscript. The authors declare that this work was produced solely by the authors and that no other individuals or entities influenced any aspects of the work including, but not limited to, the study conception and design; data acquisition, analysis and interpretation; and writing of the manuscript. The work was funded by the National Institutes of Health. No other entities provided funds for the work. The authors further declare that they have received no financial compensation from any other third parties for any aspects of the published work.'
Additional information
The online version of the original article can be found at 10.1038/gt.2016.41
Rights and permissions
About this article
Cite this article
Kaminski, R., Bella, R., Yin, C. et al. Erratum: Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study. Gene Ther 23, 696 (2016). https://doi.org/10.1038/gt.2016.45
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2016.45
This article is cited by
-
Editing out HIV: application of gene editing technology to achieve functional cure
Retrovirology (2021)
-
Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells
Scientific Reports (2020)
-
A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System
Journal of Neuroimmune Pharmacology (2019)
-
Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection
Retrovirology (2017)
-
Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
Gene Therapy (2017)